Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 989 Neoplasms 848 Carcinoma, Non-Small-Cell Lung 842 Prostatic Neoplasms 527 Neoplasm Metastasis 500 Leukemia, Myeloid, Acute 488 Melanoma 453 Colorectal Neoplasms 446 Multiple Myeloma 440 Lung Neoplasms 419 Pancreatic Neoplasms 352 Recurrence 350 Lymphoma 349 Ovarian Neoplasms 341 Lymphoma, Non-Hodgkin 327 Leukemia 323 Leukemia, Lymphocytic, Chronic, B-Cell 301 Precursor Cell Lymphoblastic Leukemia-Lymphoma 271 Carcinoma, Renal Cell 256 Head and Neck Neoplasms 246 Brain Neoplasms 243 Carcinoma, Hepatocellular 234 Squamous Cell Carcinoma of Head and Neck 231 Glioblastoma 231 Myelodysplastic Syndromes 229 Lymphoma, Large B-Cell, Diffuse 228 Lymphoma, Follicular 219 Colonic Neoplasms 191 Stomach Neoplasms 182 Rectal Neoplasms 175

Interventions

evolocumab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Lung Cancer Metastatic × Clear all

NCT05144529 2026-05-05

TOP2101

Duke University

Phase 2 Terminated

19 enrolled 16 charts

Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡